Most human cancers derive from the accumulation of multiple genetic defects contributing in different ways to the biological appearance and clinical characteristics of CANCERS.

In the NEAR FUTURE Cancer Treatment will require novel therapeutic molecules targeting specific alterations of transformed cells.
CAREBIOS is providing multiple oncological models to select new active anti - cancer drugs.